drugset

drugset / Trial / NCT07192666

Exosomes in Patients With Ocular Involvement of Sjögren's Syndrome

NCT07192666 ↗

Phase 0 Not yet recruiting 12 enrolled Guangdong ProCapZoom Biosciences Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

This study is a single-center, multiple-dosing, prospective, nonrandom, single-arm trial.

Timeline

Start: 2025-09-15
Primary completion: 2026-09-30
Completion: 2026-09-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Exosome	Other / unclassified	—	Other

Indications